SURIO-001

N/A

Report date: 2024/12/18 17:18:42
NME

Base Information

Drug NameSURIO-001
Drug Alias NameSURIO-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsOvarian NeoplasmsStomach NeoplasmsBiliary Tract Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSurio Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSurio Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsStomach NeoplasmsBiliary Tract Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A